See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: June 18, 2007

Fibrocystic Breast Disease Obesity Epilepsy (Pediatric)

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Fibrocystic Breast Disease

This study will evaluate an investigational medicated gel to see if it effectively controls breast pain. Women at least 18 with a regular menstrual cycle who have moderate-to-severe pain associated with cyclical fibrocystic breast disease may qualify.

The research site is in Tucson, Ariz.

More information

Please see



Volunteers at least 18 who have a body mass index greater than 30 kg/m2 and are generally in good health may be eligible for this study of obesity.

The research site is in Mount Pleasant, S.C.

More information

Please see


Epilepsy (Pediatric)

This study will evaluate open-label levetiracetam treatment in children with partial onset seizures. Pediatric patients with partial onset seizures for whom levetiracetam treatment will be of possible benefit, and who do not have a current diagnosis of Lennox-Gastaut syndrome or epilepsy secondary to a progressing cerebral disease may be included.

The research sites are located worldwide.

More information

Please see


Copyright 2007 Thomson CenterWatch. All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.